PLRX PLIANT THERAPEUTICS, INC.

$1.15 -2.14%

Healthcare · Pharmaceutical Preparations

PLIANT THERAPEUTICS, INC. (PLRX) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $71 million. Shares last traded at $1.15, 41.0% below their 52-week high. Over the past year the stock is down 12.6%. PLRX trades at a price-to-earnings ratio of 0.47, below the Pharmaceutical Preparations median of 16.82.

Market Cap

$71M

Shares Out

61.9M

EPS (TTM)

$-4.91

P/E Ratio

0.47

P/S Ratio

—

P/B Ratio

0.43

Dividend / Share

—

Dividend Yield

—

52-Week High

$1.94

52-Week Low

$1.09

Volume

24,733

Avg Vol (3m)

26,055.063

Performance

-0.43%

-0.87%

-13.91%

-8.76%

YTD

-9.13%

-12.60%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

42.95

SMA (50)

$1.22

SMA (200)

$1.36

Price vs SMA50

-6.02%

Price vs SMA200

-15.86%

ATR (14)

$0.05

Financials

Revenue

$0M

Net Income

$149M

Gross Margin

—

Operating Margin

—

Net Margin

—

Return on Equity

90.4%

Return on Assets

73.7%

Current Ratio

16.89

Debt / Equity

0.00

Revenue Growth (YoY)

—

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.32	2026-05-11
FY 2025	$-2.43	2026-03-11
Q3 2025	$-2.05	2025-11-06
Q2 2025	$-1.62	2025-08-07
Q1 2026	$-0.92	2026-05-11
FY 2025	$-3.47	2026-03-11

Full earnings history →

Pharmaceutical Preparations peers

PLRX vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

0.47 / 16.82 med

-97% discount

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.